AstraZeneca to open new $300 million manufacturing facility in Maryland

The plant will focus on the manufacturing of CAR-T cell therapies to enable cancer clinical trials.

AstraZeneca has announced plans to open a new manufacturing facility in Rockville, Maryland. The biopharmaceutical company will invest $300 million into the project, generating 150 new jobs in the process. Operations at the new 84,000 square-foot facility are expected to begin in 2026. According to the company, the plant will focus on the manufacturing of CAR-T cell therapies to enable cancer clinical trials. The Maryland Department of Commerce is in the process of approving a $500,000 conditional loan through the Advantage Maryland program, while Montgomery County’s Economic Development Fund will contribute an additional $100,000 conditional grant.

About the Author

Alexis Gajewski

Alexis Gajewski

Senior Content Strategist

Alexis Gajewski is a manufacturing writer and editor with nearly 20 years of experience covering the people, practices, and technologies that keep industrial facilities running. For more than a decade, she served as Senior Content Strategist for Plant Services, creating content for plant managers, engineers, and maintenance professionals on a variety of industrial topics.

During her tenure, Alexis worked to develop the brand’s digital strategy and helped launch and produce Great Question: A Manufacturing Podcast. She also created The Lighter Side of Manufacturing, a weekly blog that explored the inventive and sometimes humorous side of the industry. 

Alexis co-founded Influential Women in Manufacturing, a recognition program that honored 49 women in its first two years, earned an industry award for Best Product Launch, and received a proclamation from Illinois Governor JB Pritzker and a commendation from U.S. Senator Tammy Duckworth.

She also led newsroom operations and development at a large media company where she set editorial standards, developed training curriculum, and helped support AI adoption for more than 150 editors across 80+ brands spanning manufacturing, industrial processing, automation, and more.

Additionally, Alexis works as a freelance writer and editor, and her areas of interest include continuous improvement, the skilled workforce, and the role of emerging technology on the plant floor.

Connect with Alexis on LinkedIn

Sign up for our eNewsletters
Get the latest news and updates